Immunotherapy

SCI期刊
Immunotherapy
中文名称:
免疫疗法
期刊缩写:
IMMUNOTHERAPY-UK
影响因子:
2.7
ISSN:
print: 1750-743X
on-line: 1750-7448
研究领域:
医学-免疫学
h-index:
37
自引率:
3.60%
Gold OA文章占比:
19.84%
原创研究文献占比:
68.32%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field. Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal''s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
5.00.6900.465
学科
排名
百分位
大类:Medicine
小类:Oncology
174 / 404
57%
大类:Medicine
小类:Immunology and Allergy
124 / 233
46%
大类:Immunology and Microbiology
小类:Immunology
141 / 236
40%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
4区 医学
4区 免疫学 IMMUNOLOGY
WOS期刊分区
学科分类
Q3IMMUNOLOGY
历年影响因子
2015年2.0830
2016年2.7160
2017年3.4610
2018年3.0280
2019年2.9640
2020年4.1960
2021年4.0400
2022年2.8000
2023年2.7000
历年发表
2012年171
2013年170
2014年127
2015年120
2016年137
2017年139
2018年132
2019年156
2020年134
2021年166
2022年113
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
ENGLAND
审稿时长:
6-12 weeks
出版商:
Future Medicine Ltd.
编辑部地址:
FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB

Immunotherapy - 最新文献

Immunotherapies for prevention and treatment of type 1 diabetes.

Pub Date : 2025-03-04 DOI: 10.1080/1750743X.2025.2473311 Rebecca Jeun

Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary.

Pub Date : 2025-02-24 DOI: 10.1080/1750743X.2025.2459053 Victoria P Werth, Richard A Furie, Juanita Romero-Diaz, Sandra Navarra, Kenneth Kalunian, Ronald F van Vollenhoven, Filippa Nyberg, Benjamin H Kaffenberger, Saira Z Sheikh, Goran Radunovic, Xiaobi Huang, Hua Carroll, Himanshu Naik, Francois Gaudreault, Adam Meyers, Cristina Musselli, Nathalie Franchimont, Catherine Barbey

Part A of the LILAC study of litifilimab for systemic lupus erythematosus: a plain language summary.

Pub Date : 2025-02-24 DOI: 10.1080/1750743X.2025.2459054 Richard A Furie, Ronald F van Vollenhoven, Kenneth Kalunian, Sandra Navarra, Juanita Romero-Diaz, Victoria Werth, Xiaobi Huang, Hua Carroll, Adam Meyers, Cristina Musselli, Nathalie Franchimont, Catherine Barbey
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信